Additionally, 2‐bromopalmitate (2‐BP), which could inhibit the palmitoylation of C‐terminal domain GSDME and increase the interaction between C‐ and N‐ terminal domain of GSDME, counteracts chemotherapy drugs‐induced GSDME‐mediated pyroptosis in the cancer cells.87 Here, GSDME is linked to cancer.